Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

Dow Jones VentureWire: BIO Report on Venture Funding for Therapeutic Innovation


Today, Brian Gormley’s story – Biotech VCs Shift Away From Chronic Diseases, Report Says – highlights VC funding trends over a 10-year period. BIO released the report today showing that venture capital is shifting away from chronic diseases and increasing for rare diseases. The report categorized $38 billion of investment across more than 1,200 companies from 2004 through 2013. BIO’s report compares five-year periods before and after the financial crisis. From 2004 through 2008, for Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

National Black HIV/AIDS Awareness Day

National Black HIV/AIDS Awareness Day

In the United States, more than one million people are infected with HIV, with an estimated 50,000 newly diagnosed each year. While African Americans make up only 12-14 percent of the U.S. population they account for nearly half (44 percent) of all the new HIV infections in the U.S. (CDC). Today, as the United States observes National Black HIV/AIDS Awareness Day, we’d like to take a look at some of the scientific advancements made in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Sens. Alexander and Burr Release “Innovation for Healthier Americans” Report


Today, Senate HELP Committee Chairman Lamar Alexander (R-Tenn.) and committee member Richard Burr (R-N.C.) released a report on the challenges of ‘getting safe treatments, devices and cures to patients more quickly and effectively.’ Specifically, the report looks at what is and is not working at the Food and Drug Administration and the National Institutes of Health. The report kicks off a major initiative by the Committee to examine challenges with drug and medical device development Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post

Op-Ed in Forbes on the Threat to Philanthropy


This week, Howard Husock extols the benefits of venture philanthropy through this Forbes op-ed. In the op-ed, Husock points out that private entities conduct a significant portion of applied research toward new drug development as referenced in this 2008 Manhattan Institute paper, “The Truth About Drug Innovation”, co-authored by two researchers from the Tufts University Center for the Study of Drug Development, and Institute Fellow Benjamin Zycher: “. . .among. . . thirty-five drugs and Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Chairman Upton and Rep. DeGette Op-Ed: Can We Find Cures for 7,000 Diseases?

21st Century Cures Act

In a op-ed, Energy & Commerce Committee Chairman Fred Upton (R-MI) and Representative Diana DeGette (D-CO) provide highlights of policies that they intend to propose to help get more cures and treatments for the more than 7,000 diseases for which only 500 have cures and treatments. Chairman Upton and Rep. DeGette launched the 21st Century Cures Initiative to identify areas of reform to help ‘close the gap between the science of medicine and the Read More >

Business and Investments, Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,